November 13, 2025
The Centers for Disease Control and Prevention (CDC) and public health officials in several states, including at the Minnesota Department of Health (MDH), are investigating a multistate outbreak of infant botulism linked to ByHeart Whole Nutrition infant formula.
As of November 8, 13 infants with suspected or confirmed infant botulism have been reported in 10 states. One case was reported in Minnesota in August. No deaths have been reported. Infants ranged in age from 16 days to approximately 6 months.
On November 8, ByHeart Inc. recalled two lots of Whole Nutrition Infant Formula:
Lot: 206VABP/251261P2 (“Use by 01 Dec 2026”)
Lot: 206VABP/251131P2 (“Use by 01 Dec 2026”)
ByHeart Whole Nutrition Infant Formula is available for sale online and at major retailers nationwide. Additional lots may be recalled as the investigation continues. Parents should not use recalled infant formula and throw it away or return it to where it was purchased. If an infant has consumed ByHeart Whole Nutrition Infant Formula and has any of these symptoms, parents should reach out to their health care provider immediately:
Poor feeding
Loss of head control
Difficulty swallowing
Decreased facial expression
ByHeart Whole Nutrition Infant Formula makes up less than 1% of all infant formula sales in the United States, and this outbreak does not create shortage concerns of infant formula for parents and caregivers.
Additional information about this outbreak can be found on the CDC’s website: Infant Botulism Outbreak Linked to Infant Formula, November 2025.
Additional information about botulism can be found on the MDH website: Botulism (Clostridium botulinum toxin).
November 13, 2025
At its November 8 meeting, the MMA Board of Trustees approved a list of priorities that aim to make Minnesota the best place to practice and Minnesotans the healthiest in the nation.
November 13, 2025
The years-long saga between the University of Minnesota and M Health Fairview took another twist this week as Fairview and University of Minnesota Physicians (UMP) announced a separate 10-year deal without the university's approval.
November 13, 2025
The Office of the Minnesota Secretary of State (OSS) is accepting applications for two open physician seats on the Minnesota Drug Formulary Committee.